Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017
И. И. Дедов(Endocrinology Research Center), М. А. Исаков(Endocrinology Research Center), Marina V. Shestakova, Anna V. Zheleznyakova(Endocrinology Research Center), Olga K. Vikulova
Cited by 140
Related Papers
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
|The Lancet|2023|676
Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 9th edition
|Diabetes Mellitus|2019|257
The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)
|Diabetes Mellitus|2016|254
Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022
|Diabetes Mellitus|2023|248
Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 11th Edition
|Diabetes Mellitus|2023|206